EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A PIKfyve modulator combined with an integrated stress response inhibitor to treat lysosomal storage diseases

William C Hou, Lynée A Massey, Derek Rhoades iD, Yin Wu, Wen Ren, Chiara Frank, Herman S Overkleeft iD, Jeffrey W Kelly

Proceedings of the National Academy of Sciences · 2024

DOI: 10.1073/pnas.2320257121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von William C Hou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92122. Hauptthemen laut MEDLINE: Phosphatidylinositol 3-Kinases, Lysosomes, Glucosylceramidase, Fibroblasts. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, HHS | NIH | National Institute on Aging (NIA), Rainwater Charitable Foundation (RCF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lysosomal degradation pathways coordinate the clearance of superfluous and damaged cellular components. Compromised lysosomal degradation is a hallmark of many degenerative diseases, including lysosomal storage diseases (LSDs), which are caused by loss-of-function mutations within both alleles of a lysosomal hydrolase, leading to lysosomal substrate accumulation. Gaucher’s disease, characterized by

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphatidylinositol 3-KinasesLysosomesGlucosylceramidaseFibroblastsLysosomal Storage DiseasesHumansGaucher DiseasePhosphoinositide-3 Kinase Inhibitors

Stichwörter der Autor:innen

Gaucher’s diseasePIKfyveParkinson’s diseaseintegrated stress responselysosomal storage disease

Substanzen

PIKFYVE protein, humanPhosphatidylinositol 3-KinasesGlucosylceramidasePhosphoinositide-3 Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92122.
  • Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92122.
  • Department of Bio-organic Synthesis, Leiden Institute of Chemistry, Leiden University, Leiden 2333 CC, The Netherlands.

ORCID-Profile: Derek Rhoades, Herman S Overkleeft

Förderung

  • NIA NIH HHS
  • HHS | NIH | National Institute on Aging (NIA)
  • Rainwater Charitable Foundation (RCF)
  • JBP Foundation

Zitieren

APA

Hou, W. C., Massey, L. A., Rhoades, D., Wu, Y., Ren, W., Frank, C., Overkleeft, H. S., & Kelly, J. W. (2024). A PIKfyve modulator combined with an integrated stress response inhibitor to treat lysosomal storage diseases. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2320257121

Vancouver

Hou WC, Massey LA, Rhoades D, Wu Y, Ren W, Frank C, et al. A PIKfyve modulator combined with an integrated stress response inhibitor to treat lysosomal storage diseases. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2320257121

BibTeX
@article{Hou2024,
  author = {Hou, William C and Massey, Lynée A and Rhoades, Derek and Wu, Yin and Ren, Wen and Frank, Chiara and Overkleeft, Herman S and Kelly, Jeffrey W},
  title = {A PIKfyve modulator combined with an integrated stress response inhibitor to treat lysosomal storage diseases},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  doi = {10.1073/pnas.2320257121}
}
Kostenlos starten →